The key to Tachyon’s advantage lies in the automation of the software that is able to optimize multiple molecules in faster runs than have ever been possible through classical computing solutions. With each run, internal models are updated, so that the more projects it has completed, the more effiective and efficient Tachyontm becomes. Using machine learning algorithms on internally curated data from previous runs, leads to faster outcomes as well as novel solutions to chemical inquiries. The power of quantum computers, specifically annealing computers, to perform complex optimization solutions has been well documented since the middle of 2022, when logistics solutions and other optimization solutions came to market.
21st Century Drug Design
By utilizing the power of quantum computing to assess a large chemical space at once, rather than taking many small corrective steps, Tachyontm is able to analyze chemical libraries numbering in the billions of molecules in a matter of seconds. This provides a distinct advantage for drug design, by efficiently finding novel molecules that are promising candidates for drug design. Because Tachyontm is system agnostic, Polarisqb has the flexibility and versatility to be able to work in multiple diseases and indications.
Work with D-Wave Cited as Changing Drug Discovery and Quantum Computing
Recently, POLARISqb has been in the news for the revolutionary work that we are doing in drug discovery. An integral part of that progress is our work with quantum providers like D-Wave Systems from Toronto, Canada. As this article from Inside Quantum Technology by Kenna Hughes-Castleberry details, the partnership between our company and D-Wave represents a way that quantum annealing Continue Reading
POLARISqb talks with QuBites from Valorem Reply
QuBites S6 E6 We were excited to engage in this fantastic conversation with Rene Schulte about our company and the work that we are doing. He talks with our CEO, Dr. Shahar Keinan, about utilizing the power of quantum optimization to power the quantum drug discovery we have made in the last three years. The episode talks about the progress in Continue Reading
Quantum Computing for the Real World: Ars Technica writes about POLARISqb and D-Wave
Just as the team was returning from some well-deserved time off for the winter break, we got some fantastic news. The publication Ars Technica, a highly-respected group that reports on cutting-edge developments in the tech world, was set to release an article about POLARISqb and D-Wave, the quantum computer we use in our drug discovery pipeline. We were thrilled to Continue Reading
Hackathons Power Collaboration and Innovation
An essential part of our philosophy for success in drug discovery is our quarterly hackathon, a hands-on technical challenge that our entire team works together to solve. As a data and science-led organization, these hackathons keep our team working collaboratively across departments and integrating innovations from across the fields of bioscience, pharmaceuticals, computing, and quantum technology. For example, the goal Continue Reading
QC Designs a Different Molecule
Drug discovery is a complicated process of identifying a small molecule that can bind to a specific protein pocket and change disease progression by blocking (or enhancing) the activity of that protein. Not only does it have to interact with the protein in a favorable manner, but it also must have the properties that make it both bioavailable and pharmacologically Continue Reading